Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience


SOYER N. , Patir P., Uysal A., Duran M., Unal H. D. , Durusoy R. , ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.48, ss.777-785, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 48 Konu: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.3906/sag-1712-160
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.777-785

Özet

Background/aim: In Turkey, lenalidomide plus dexamethasone (RD) has been used to treat relapsed/refractory multiple myeloma (RRMM) since 2010. This retrospective, single-center study evaluated the efficacy and tolerability of RD in patients with RRMM between October 2010 and June 2016.